Back to Authors

Kadia, Tapan

A5079463556 | I1343551460

Mayo Clinic

The University of Texas MD Anderson Cancer Center

Citations 1

Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study

Blood Advances | January 8, 2024 | Volume: 8 | Issue: 4 | Pages: 842-845

10.1182/bloodadvances.2023012248 | PMID 38190628